Oscar E. Bruck
Helsinki, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
TIM3 blockade with hypomethylating therapy restores NK-cell and cytotoxic CD4+ T-cell activity in patients with AML or MDS.
Journal: Cancer immunology research
Published: February 04, 2026
Improved Outcomes Following the Adoption of Targeted Therapies in High-Risk Chronic Lymphocytic Leukemia Treated in Southern Finland.
Journal: Clinical lymphoma, myeloma & leukemia
Published: October 02, 2025
Novel therapies in myeloid neoplasms show limited benefit and increased costs over 15 years of follow-up in Southern Finland.
Journal: Annals of hematology
Published: September 11, 2025
Enhancing Severe Neutropenia Prediction: PKPD-Informed Labeling for Machine Learning Models Trained on Real-World Data.
Journal: Clinical pharmacology and therapeutics
Published: July 30, 2025
Tumor cell FAP orchestrates EMT and immune suppression in aggressive localized ccRCC.
Journal: Theranostics
Published: May 28, 2025
Granulocyte abundance and maturation state at diagnosis predicts treatment-free remission in CML.
Journal: Leukemia
Published: May 21, 2025
Evaluating Pediatric Reference Ranges for Extended Immunophenotyping from a Finnish Cohort against Published References.
Journal: Journal of clinical immunology
Published: May 06, 2025
Predicting antigen-specific T-cell immunity against Wilms tumor 1 in hematologic cancer.
Journal: Leukemia
Published: March 14, 2025
European health regulations reduce registry-based research.
Journal: Health research policy and systems
Published: July 19, 2024
Standardized translations of the Lee Chronic GvHD Symptom Scale to 12 European languages: an EU COST Action cGvHD Eurograft project.
Journal: Bone marrow transplantation
Published: May 07, 2024
Last Updated: 09/26/2026